skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
Material Type:
Article
Add to My Research

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

Virus research, 2018-03, Vol.248, p.53-62 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1872-7492 ;EISSN: 1872-7492 ;DOI: 10.1016/j.virusres.2018.02.016 ;PMID: 29477639

Digital Resources/Online E-Resources

2
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Material Type:
Article
Add to My Research

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Nature Medicine, 2011-05, Vol.17 (5), p.589-595 [Peer Reviewed Journal]

COPYRIGHT 2011 Nature Publishing Group ;Copyright Nature Publishing Group May 2011 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/nm.2341 ;PMID: 21516087

Full text available

3
Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB
Material Type:
Article
Add to My Research

Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB

PLoS pathogens, 2018-07, Vol.14 (7), p.e1007111-e1007111 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Bruening et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;2018 Bruening et al 2018 Bruening et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1007111 ;PMID: 30024968

Full text available

4
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81
Material Type:
Article
Add to My Research

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81

Hepatology (Baltimore, Md.), 2007-12, Vol.46 (6), p.1722-31 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0270-9139 ;EISSN: 1527-3350 ;DOI: 10.1002/hep.21994 ;PMID: 18000990

Digital Resources/Online E-Resources

5
Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
Material Type:
Article
Add to My Research

Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry

Cell reports (Cambridge), 2015-08, Vol.12 (5), p.864-878 [Peer Reviewed Journal]

2015 The Authors ;Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;2015 The Authors 2015 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2015.06.063 ;PMID: 26212323

Full text available

6
High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI
Material Type:
Article
Add to My Research

High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI

The Journal of biological chemistry, 2006-07, Vol.281 (27), p.18285-18295 [Peer Reviewed Journal]

2006 © 2006 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0021-9258 ;EISSN: 1083-351X ;DOI: 10.1074/jbc.M602706200 ;PMID: 16675450

Full text available

7
Magnesium Complexes of Ladanein: A Beneficial Strategy for Stabilizing Polyphenolic Antivirals
Material Type:
Article
Add to My Research

Magnesium Complexes of Ladanein: A Beneficial Strategy for Stabilizing Polyphenolic Antivirals

European journal of inorganic chemistry, 2021-07, Vol.2021 (27), p.2764-2772 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1434-1948 ;EISSN: 1099-0682 ;DOI: 10.1002/ejic.202100341

Digital Resources/Online E-Resources

8
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry
Material Type:
Article
Add to My Research

Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry

Antiviral research, 2020-05, Vol.177 [Peer Reviewed Journal]

Attribution - NonCommercial - NoDerivatives ;ISSN: 0166-3542 ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2020.104774 ;PMID: 32197980

Digital Resources/Online E-Resources

9
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages
Material Type:
Article
Add to My Research

Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages

Antimicrobial agents and chemotherapy, 2022-12, Vol.66 (12), p.e0103222-e0103222 [Peer Reviewed Journal]

Copyright © 2022 Sake et al. ;Attribution ;Copyright © 2022 Sake et al. 2022 Sake et al. ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.01032-22 ;PMID: 36346232

Full text available

10
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Material Type:
Article
Add to My Research

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor

Nature communications, 2024-02, Vol.15 (1), p.1173-1173 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-024-45241-y ;PMID: 38332002

Full text available

11
Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies
Material Type:
Article
Add to My Research

Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies

Gastroenterology (New York, N.Y. 1943), 2012-07, Vol.143 (1), p.223-233.e9 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0016-5085 ;EISSN: 1528-0012 ;DOI: 10.1053/j.gastro.2012.04.006 ;PMID: 22503792

Digital Resources/Online E-Resources

12
Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2
Material Type:
Article
Add to My Research

Conformational Flexibility in the Immunoglobulin-Like Domain of the Hepatitis C Virus Glycoprotein E2

mBio, 2017-05, Vol.8 (3), p.e00382-17. [Peer Reviewed Journal]

Attribution ;ISSN: 2161-2129 ;EISSN: 2150-7511 ;DOI: 10.1128/mBio.00382 ;PMID: 28512091

Full text available

13
The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination
Material Type:
Article
Add to My Research

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

Hepatology (Baltimore, Md.), 2013-02, Vol.57 (2), p.492-504 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0270-9139 ;EISSN: 1527-3350 ;DOI: 10.1002/hep.26097 ;PMID: 23081796

Digital Resources/Online E-Resources

14
A lymphotoxin-driven pathway to hepatocellular carcinoma: Sustained hepatic LT signaling causes HCC
Material Type:
Article
Add to My Research

A lymphotoxin-driven pathway to hepatocellular carcinoma: Sustained hepatic LT signaling causes HCC

Cancer cell, 2009-10, Vol.16 (4), p.295-308 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccr.2009.08.021 ;PMID: 19800575

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait